NASDAQ: INSMInsmed Inc Stock Ownership - Who owns Insmed?
Insider buying vs selling
Have Insmed Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| William Lewis | Chair and CEO | 2024-02-28 | 50,000 | $12.58 | $629.00kBuy |
| Martina Md Flammer | Chief Medical Officer | 2024-01-12 | 4,667 | $28.63 | $133.62kSell |
| Roger Adsett | Chief Operating Officer | 2024-01-12 | 5,251 | $28.63 | $150.34kSell |
| Martina Md Flammer | Chief Medical Officer | 2024-01-10 | 1,245 | $28.90 | $35.98kSell |
| Roger Adsett | Chief Operating Officer | 2024-01-10 | 3,536 | $28.90 | $102.19kSell |
| Roger Adsett | Chief Operating Officer | 2024-01-09 | 3,837 | $29.25 | $112.23kSell |
| Orlov S. Nicole Schaeffer | Chief People Strategy Officer | 2024-01-09 | 3,165 | $28.74 | $90.96kSell |
| Michael Alexander Smith | General Counsel Senior VP | 2024-01-09 | 2,373 | $28.76 | $68.25kSell |
| John Drayton Wise | Chief Commercial Officer | 2024-01-09 | 1,861 | $28.78 | $53.56kSell |
| Sara Bonstein | Chief Financial Officer | 2024-01-09 | 4,497 | $29.18 | $131.22kSell |
INSM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when INSM insiders and whales buy or sell their stock.
INSM Shareholders
What type of owners hold Insmed Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Richard S. Kollender | 14.76% | 21,924,540 | $543.73M | Insider |
| Vanguard Group Inc | 9.51% | 14,125,521 | $350.31M | Institution |
| Blackrock Inc | 7.74% | 11,492,282 | $285.01M | Institution |
| Price T Rowe Associates Inc | 7.25% | 10,763,771 | $266.94M | Institution |
| State Street Corp | 3.99% | 5,929,933 | $147.06M | Institution |
| T Rowe Price Investment Management Inc | 3.94% | 5,850,606 | $145.10M | Institution |
| Palo Alto Investors LP | 3.71% | 5,511,721 | $136.69M | Institution |
| Deep Track Capital LP | 3.60% | 5,350,000 | $132.68M | Institution |
| Fmr LLC | 3.43% | 5,091,614 | $126.27M | Institution |
| Macquarie Group Ltd | 3.13% | 4,651,492 | $115.36M | Institution |
INSM vs Biotech Stocks
Insmed Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.